Clinical Study

Identification Of A Plasma Proteomic Signature For Lung Cancer

Posted Date: May 15, 2019

  • Investigator: Sandra Starnes
  • Type of Study: Drug

This is a clinical research study of an investigational blood testing by the sponsor. The Food and Drug Administration (FDA) considers an investigational test to be a test that is not approved for general use; therefore it is not commercially available. The purpose of this study is to use a new lab


Eligible Patients Must Have A Lung Nodule And Have Been Scheduled For Serial Assessments Or A Surgic


1013-11/12, Blood Test, Lung Cancer, Nodules

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.